Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss
The starting dose is about receptor adaptation, not about achieving a specific blood concentration per kilogram of body weight
There are serious health risks associated with these medications and significant benefits for patients who are sick and have medical issues. Both Ozempic and Wegovy have been listed on the FDAs drug shortage list for years, due to the drugs meteoric rise in popularity
(Note there is an analogous enzyme in the mitochondria for the urea cycle termed carbamoyl phosphate synthetase I, which also generates carbamoyl phosphate.) Of clinical importance is the intermediate orotate
However, keto is not a complete substitute for the appetite suppression the drug was providing
Another weight loss injection that can help you navigate your weight loss journey is tirzepatide